As on Wednesday, Quest Diagnostics, Inc (NYSE: DGX) got off with the flyer as it spiked 0.65% to $173.62, before settling in for the price of $172.5 at the close. Taking a more long-term approach, DGX posted a 52-week range of $136.99-$182.38.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 4.04%. Meanwhile, its Annual Earning per share during the time was 4.04%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.63%. This publicly-traded company’s shares outstanding now amounts to $112.00 million, simultaneously with a float of $111.01 million. The organization now has a market capitalization sitting at $19.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $176.25, while the 200-day Moving Average is $164.32.
Quest Diagnostics, Inc (DGX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Diagnostics & Research industry. Quest Diagnostics, Inc’s current insider ownership accounts for 0.56%, in contrast to 94.48% institutional ownership. According to the most recent insider trade that took place on May 12 ’25, this organization’s SVP & Chief Commercial Officer sold 874 shares at the rate of 175.72, making the entire transaction reach 153,579 in total value, affecting insider ownership by 8,372. Preceding that transaction, on May 13 ’25, Company’s SVP & Chief Commercial Officer sold 874 for 175.31, making the whole transaction’s value amount to 153,221. This particular insider is now the holder of 7,498 in total.
Quest Diagnostics, Inc (DGX) Earnings and Revenue Records
Quest Diagnostics, Inc’s EPS increase for this current 12-month fiscal period is 8.63% and is forecasted to reach 10.50 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.25% through the next 5 years, which can be compared against the 4.04% growth it accomplished over the previous five years trading on the market.
Quest Diagnostics, Inc (NYSE: DGX) Trading Performance Indicators
Let’s observe the current performance indicators for Quest Diagnostics, Inc (DGX). It’s Quick Ratio in the last reported quarter now stands at 1.31. Alongside those numbers, its PE Ratio stands at $21.94, and its Beta score is 0.47. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.91. Similarly, its price to free cash flow for trailing twelve months is now 18.35.
In the same vein, DGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 7.91, a figure that is expected to reach 2.57 in the next quarter, and analysts are predicting that it will be 10.50 at the market close of one year from today.
Technical Analysis of Quest Diagnostics, Inc (DGX)
Through scrutinizing the latest numbers posted by the [Quest Diagnostics, Inc, DGX], it can be observed that its last 5-days Average volume of 0.82 million was lower the volume of 1.16 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 12.92% While, its Average True Range was 36.61%.
Raw Stochastic average of Quest Diagnostics, Inc (DGX) in the period of the previous 100 days is set at 65.22%, which indicates a major rise in contrast to 23.63% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.78 that was lower than 3.65 volatility it exhibited in the past 100-days period.
